Science Explorer Back to mapMap

Most cited papers in Parkinson's Disease and Spinal Disorders

Parkinson's Disease and Spinal Disorders

What are the most cited papers in Parkinson's Disease and Spinal Disorders?

The most cited paper in Parkinson's Disease and Spinal Disorders is "Parkinson's disease: clinical features and diagnosis" (Joseph J. Jankovic, 2008), with 5,789 citations. Next come "Diagnosis and Treatment of Parkinson Disease" (2,949) and "A classification of chronic pain for ICD-11" (2,856).

Showing 50 of 98 papers. Every paper with more than 439 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Parkinson's disease: clinical features and diagnosis Joseph J. Jankovic · Journal of Neurology Neurosurgery & Psychiatry Open access 14 Mar 2008 5,789
2 Diagnosis and Treatment of Parkinson Disease Melissa J. Armstrong, Michael S. Okun · JAMA 11 Feb 2020 2,949
3 A classification of chronic pain for ICD-11 Rolf‐Detlef Treede et al. · Pain Open access 6 Apr 2015 2,856
4 Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease Paul Krack, Alina Batir, Nadège Van Blercom et al. · New England Journal of Medicine Open access 12 Nov 2003 2,255
5 El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis Benjamin Rix Brooks · Journal of the Neurological Sciences Jul 1994 2,149
6 Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics Scott W. Woods · The Journal of Clinical Psychiatry 15 Jun 2003 2,065
7 Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Walter O. Spitzer, Mary Louise Skovron, L. Rachid Salmi et al. · PubMed 15 Apr 1995 1,866
8 Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease Patricia Dowsey Limousin, Paul Krack, Pierre Pollak et al. · New England Journal of Medicine Open access 15 Oct 1998 1,864
9 Valvular Heart Disease Associated with Fenfluramine–Phentermine Heidi M. Connolly, Jack L. Crary, Michael D. McGoon et al. · New England Journal of Medicine Open access 28 Aug 1997 1,640
10 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups Ingrid E. Lundberg et al. · Annals of the Rheumatic Diseases Open access 27 Oct 2017 1,587
11 Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study Daniel G. Healy et al. · The Lancet Neurology Open access 8 Jun 2008 1,586
12 A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa Olivier Rascol, David J. Brooks, Amos D. Korczyn et al. · New England Journal of Medicine Open access 18 May 2000 1,542
13 Pharmacological Treatment of Parkinson Disease Barbara S. Connolly, Anthony E. Lang · JAMA 22 Apr 2014 1,511
14 Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil Pierre N. Tariot, Martin Rhys Farlow, George Thomas Grossberg et al. · JAMA 20 Jan 2004 1,406
15 What contributes to quality of life in patients with Parkinson's disease? Anette E. Schrag · Journal of Neurology Neurosurgery & Psychiatry Open access Sep 2000 1,389
16 Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study Catherine Louise Hill, Yuqing Zhang, Bárður Sigurgeirsson et al. · The Lancet 2001 1,197
17 International consensus guidance for management of myasthenia gravis Donald B. Sanders, Gil I. Wolfe, Michael G Benatar et al. · Neurology Open access 29 Jun 2016 1,190
18 Myasthenia Gravis Nils Erik Gilhus · New England Journal of Medicine 28 Dec 2016 1,063
19 International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease Susan Helen Fox, Regina Katzenschlager, Shen‐Yang Lim et al. · Movement Disorders Open access 23 Mar 2018 1,006
20 Deep Brain Stimulation for Parkinson Disease Jeff M. Bronstein et al. · Archives of Neurology Open access 11 Oct 2010 981
21 A New Approach to the Classification of Idiopathic Inflammatory Myopathy Lori A. Love, Richard L. Leff, D. D. Fraser et al. · Medicine Nov 1991 975
22 How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale Glenn T. Stebbins, Christopher G. Goetz, David John Burn et al. · Movement Disorders 13 Feb 2013 959
23 Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial Jeffrey L. Cummings, Stuart Isaacson, Roger Mills et al. · The Lancet 31 Oct 2013 955
24 Polymyositis, Dermatomyositis, and Inclusion-Body Myositis Marinos C. Dalakas · New England Journal of Medicine 21 Nov 1991 948
25 Randomized Trial of Thymectomy in Myasthenia Gravis Gil I. Wolfe et al. · New England Journal of Medicine Open access 10 Aug 2016 933
26 Atypical Antipsychotics: Mechanism of Action Philip M. Seeman · The Canadian Journal of Psychiatry Open access Feb 2002 905
27 A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease C. Warren Olanow, Olivier Rascol, Robert A. Hauser et al. · New England Journal of Medicine Open access 23 Sep 2009 901
28 Tai Chi and Postural Stability in Patients with Parkinson's Disease Fuzhong Li, Peter Harmer, Kathleen M. Fitzgerald et al. · New England Journal of Medicine Open access 8 Feb 2012 898
29 Test-Retest Reliability and Minimal Detectable Change on Balance and Ambulation Tests, the 36-Item Short-Form Health Survey, and the Unified Parkinson Disease Rating Scale in People With Parkinsonism Teresa M Steffen, Megan Seney · Physical Therapy 20 Mar 2008 878
30 Parkinson Disease in Twins Caroline M. Tanner, Ruth Ottman, Samuel M. Goldman et al. · JAMA 27 Jan 1999 872
31 Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy Jose Angel Obeso et al. · Movement Disorders Open access Sep 2017 871
32 Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature Adriano Chiò, Giancarlo Logroscino, Bryan J. Traynor et al. · Neuroepidemiology ReviewOpen access 2013 870
33 Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial Alice Nieuwboer, Gert Kwakkel, Lynn Rochester et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 17 Jan 2007 863
34 Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial Robert G. Holloway et al. · JAMA 18 Oct 2000 802
35 Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Masato Hasegawa, Tetsuaki Arai, Takashi Nonaka et al. · Annals of Neurology Open access 10 Jun 2008 801
36 Risk of Cancer in Patients with Dermatomyositis or Polymyositis Bárður Sigurgeirsson, Bernt Lindelöf, Olof Edhag et al. · New England Journal of Medicine Open access 6 Feb 1992 796
37 Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study Dag Aarsland, Jan Petter Larsen, Elise Tandberg et al. · Journal of the American Geriatrics Society Aug 2000 790
38 Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial Vincent J.J. Odekerken, Teus van Laar, Michiel J. Staal et al. · The Lancet Neurology 15 Nov 2012 775
39 Incidence of amyotrophic lateral sclerosis in Europe Giancarlo Logroscino, Bryan J Traynor, Orla M. Hardiman et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 25 Aug 2009 771
40 A systematic review of population based epidemiological studies in Myasthenia Gravis Aisling S. Carr, Chris R. Cardwell, Peter O McCarron et al. · BMC Neurology ReviewOpen access 18 Jun 2010 768
41 Gender differences in Parkinson's disease Charlotte A. Haaxma, Bastiaan R. Bloem, George F. Borm et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 14 Nov 2006 760
42 Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis Shinji Sato, Michito Hirakata, Masataka Kuwana et al. · Arthritis & Rheumatism May 2005 755
43 Lifetime course of myasthenia gravis David Tim Grob, Norman G. Brunner, Tatsuji Namba et al. · Muscle & Nerve 4 Dec 2007 739
44 New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis Stefan Leucht, Kristian Wahlbeck, Johannes Hamann et al. · The Lancet Review May 2003 727
45 Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies Christoph Ulrich Correll, Stefan Leucht, John Michael Kane · American Journal of Psychiatry Review Mar 2004 711
46 Risk of dementia in Parkinson’s disease Dag Aarsland, Kjeld Andersen, Jan Otto Larsen et al. · Neurology 27 Mar 2001 708
47 Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial Chester V. Oddis, Ann M. Reed, Rohit Aggarwal et al. · Arthritis & Rheumatism Open access 2 Nov 2012 703
48 The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort Caroline H. Williams‐Gray, Sarah Mason, Jonathan Evans et al. · Journal of Neurology Neurosurgery & Psychiatry 18 Jun 2013 699
49 THE LAMBERT-EATON MYASTHENIC SYNDROME Jane O’Neill, Nicholas M.F. Murray, John Newsom–Davis · Brain 1988 686
50 Prediagnostic presentations of Parkinson's disease in primary care: a case-control study Anette E. Schrag, Laura Horsfall, Kate R Walters et al. · The Lancet Neurology Open access 26 Nov 2014 684

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.